Go offline with the Player FM app!
#300 - Special episode: Peter on exercise, fasting, nutrition, stem cells, geroprotective drugs, and more — promising interventions or just noise?
Manage episode 416721408 series 2394217
View the Show Notes Page for This Episode
Become a Member to Receive Exclusive Content
Sign Up to Receive Peter’s Weekly Newsletter
In this special edition celebrating 300 episodes of The Drive, Peter discusses a variety of popular topics and health interventions and classifies them based on their level of evidence and relevance using the following categories: proven, promising, fuzzy, noise, and nonsense. Peter first delves into the topic of geroprotective molecules, covering rapamycin, metformin, NAD and its precursors, and resveratrol. Next, he explores the significance of metrics like VO2 max and muscle mass, as well as emerging concepts like blood flow restriction and stem cells. The conversation extends to nutrition, addressing questions surrounding long-term fasting, sugar consumption, sugar substitutes, and the contentious role of red meat in cancer. Peter not only provides his current stance on each topic—most of which have been covered in great detail in the previous 300 episodes—but also reflects on how his opinion may have evolved over the years.
We discuss:
- Defining the categories of “proven, promising, fuzzy, noise, and nonsense” [3:15];
- Rapamycin [9:30];
- Metformin [17:00];
- NAD and its precursors [24:30];
- Resveratrol [32:45];
- The importance of VO2 max, muscle mass, and muscular strength for lifespan [38:15];
- Blood flow restriction (BFR) training [44:00];
- Using stem cells to treat osteoarthritis or injury [51:30];
- Fasting as a tool for longevity (and why Peter stopped his fasting protocol) [55:45];
- The energy balance theory [1:06:30];
- The idea that sugar is poison [1:12:00];
- The idea that sugar substitutes are dangerous [1:22:15];
- The debate on red meat and cancer [1:28:45]; and
- More.
Connect With Peter on Twitter, Instagram, Facebook and YouTube
364 episodes
Manage episode 416721408 series 2394217
View the Show Notes Page for This Episode
Become a Member to Receive Exclusive Content
Sign Up to Receive Peter’s Weekly Newsletter
In this special edition celebrating 300 episodes of The Drive, Peter discusses a variety of popular topics and health interventions and classifies them based on their level of evidence and relevance using the following categories: proven, promising, fuzzy, noise, and nonsense. Peter first delves into the topic of geroprotective molecules, covering rapamycin, metformin, NAD and its precursors, and resveratrol. Next, he explores the significance of metrics like VO2 max and muscle mass, as well as emerging concepts like blood flow restriction and stem cells. The conversation extends to nutrition, addressing questions surrounding long-term fasting, sugar consumption, sugar substitutes, and the contentious role of red meat in cancer. Peter not only provides his current stance on each topic—most of which have been covered in great detail in the previous 300 episodes—but also reflects on how his opinion may have evolved over the years.
We discuss:
- Defining the categories of “proven, promising, fuzzy, noise, and nonsense” [3:15];
- Rapamycin [9:30];
- Metformin [17:00];
- NAD and its precursors [24:30];
- Resveratrol [32:45];
- The importance of VO2 max, muscle mass, and muscular strength for lifespan [38:15];
- Blood flow restriction (BFR) training [44:00];
- Using stem cells to treat osteoarthritis or injury [51:30];
- Fasting as a tool for longevity (and why Peter stopped his fasting protocol) [55:45];
- The energy balance theory [1:06:30];
- The idea that sugar is poison [1:12:00];
- The idea that sugar substitutes are dangerous [1:22:15];
- The debate on red meat and cancer [1:28:45]; and
- More.
Connect With Peter on Twitter, Instagram, Facebook and YouTube
364 episodes
All episodes
×Welcome to Player FM!
Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.